Who Gains and Who Pays: Health Care as It Is, Single Payer, and the Options Between

The country spent $5.3 trillion on health care in 2024, and every dollar of it was someone's income. Any change in how care is paid for moves money between patients, taxpayers, employers, hospitals, doctors, insurers and drugmakers. Who comes out ahead and who pays under each option, what the evidence settles, and what it leaves to values.

The short version

Every way of paying for health care is also a way of dividing nearly a fifth of the economy, so the question to ask of any option is who pays more, who pays less, and who gets paid less. The country spent $5.3 trillion on care in 2024. It pays more than other rich countries mostly because of prices, not because it uses more care. Under current law coverage is shrinking: the extra marketplace credits ended in 2025, Medicaid work requirements start by January 2027, and CBO expects about 14 million more people uninsured by 2034 as a result. Single payer would cover everyone with no premiums or deductibles and move most spending onto the federal budget. Estimates of the total range from about 20% lower to 21% higher than today, depending mostly on what it would pay hospitals, doctors and drugmakers. The options between change less: restoring the credits, a public option, capping private prices, or sending subsidy money to people instead of insurers. The evidence settles more about who gains under each than about which trade is worth it.

New articles and charts arrive in one short email on Monday mornings. Get the weekly digest

The analogy

A bazaar where every buyer haggles separately. Each insurer, each employer that runs its own plan, Medicare and every state's Medicaid program strike their own deals with each hospital and doctor, so the same knee replacement carries a different price depending on who is paying. Single payer leaves the stalls but replaces the haggling buyers with one buyer, who posts one price list for everyone. A public option opens one stall with posted prices that anyone may choose. Rate setting makes every stall charge posted prices but leaves the buyers separate. Sending subsidy money to shoppers instead of to insurers on their behalf, the administration's approach, hands buyers the cash and counts on them to bargain harder. In every version, what the stalls take in pays their staff, their suppliers and their owners, so a lower price is somebody's lower income.

Most figures below are as of late October 2026.

Where the money comes from now

National health spending was $5.3 trillion in 2024, or $15,474 per person, 18.0% of GDP. Counting who finances it rather than who writes the checks, the federal government paid 31%, households 28%, private businesses 18%, state and local governments 16%, and other private sources 6% (Hartman and others). CMS's actuaries project spending to keep growing faster than the economy, to 20.6% of GDP in 2034, while the share of people with insurance falls from 91.8% to 90.5%.

The United States spends more than other rich countries mostly because of what it pays, not how much care it gets. In 2023 it spent $13,432 per person, 1.8 times the average of eleven comparable countries, on an international measure that leaves out the research and construction in the CMS figure. Americans have just over half as many in-person doctor visits per person as the peer average, fewer hospital stays and shorter ones. For a coronary angioplasty in 2022, traditional Medicare paid 2.9 times the average of peer countries' public plans, and private insurers paid from 3.1 times what the United Kingdom pays to 10.3 times what Germany pays. A 2018 study in JAMA comparing the United States with ten other high-income countries reached the same conclusion: use of care was largely similar, and prices, including for drugs and labor, and administrative costs drove the difference.

Within the country the picture is different. Across U.S. counties, how much care people use explains more of the variation in spending than its price: about 65% in a 2025 study, with price and intensity of care about 24%. Among the privately insured, price and quantity each account for about half of the variation between regions; in Medicare, which sets its prices, almost all of it is quantity.

How much goes to administration depends on what counts. The OECD's narrow category, insurers' and governments' own overhead, was 8% of U.S. health spending against 1% to 3% elsewhere. Counting providers' billing and back offices too, researchers from McKinsey and Harvard put it at about $950 billion of $3.8 trillion in 2019, a quarter, and estimated that $265 billion of it could be saved by simplifying the current system. Steffie Woolhandler, David Himmelstein and a coauthor, longtime advocates of single payer, counted 34% in 2017, against 17% in Canada.

So the options below differ mainly in how they would lower prices, extend coverage, or both, and each runs into the same fact: a price is someone's income.

Keeping things as they are

"As they are" is not standing still. Under current law, coverage is shrinking. The extra marketplace tax credits Congress added in 2021 expired at the end of 2025. The 2025 reconciliation law requires states to start Medicaid work requirements for adults covered by the expansion by January 1, 2027 (Nebraska and Montana started earlier; a state can seek more time, to the end of 2028 at the latest), and to recheck those adults' eligibility every six months at renewals from December 31, 2026. CBO estimates the law will leave 10 million more people uninsured in 2034, and the expiring credits another 4.2 million. The Census Bureau counted 26.7 million people, 7.9%, uninsured for all of 2025. CBO, counting people uninsured in an average month, projects 30 million in 2026 and 37 million in 2036.

Who gains. Hospitals and doctors with many privately insured patients: employers and private insurers paid hospitals 254% of what Medicare would have paid in 2022, and those payments carry many hospitals' finances. Drugmakers, which charge more here than in other rich countries: even the prices Medicare negotiated for its first ten drugs are 2.8 times the peer average. Insurers, pharmacy benefit managers and the people who handle claims and billing, whose work grows with the system's complexity. People with good coverage through work, and most insured people like theirs: 65% rate their own coverage excellent or good, while 24% say that of coverage in the country. And they get care quickly by international standards: in a 2016 survey, 6% of Americans who needed a specialist waited two months or more, against 30% of Canadians. Their coverage is also subsidized. Premiums paid through work are left out of taxable income, a break worth $471 billion in 2026, and because it is an exclusion from income it is worth more to people in higher tax brackets.

Who pays. People who buy their own coverage: after the extra credits expired, what marketplace enrollees paid rose 58% on average, and enrollment people paid for fell 12%, to 19.2 million (details in what health insurance costs). Adults with low incomes in the states that expanded Medicaid, who face the new paperwork and work rules. People with no coverage at all, and people whose coverage leaves bills they can't easily pay: in the Commonwealth Fund's 2026 survey, 23% of working-age adults were insured all year but underinsured, and nearly a third were paying off medical bills or debt. And the hospitals that treat patients without being paid. Workers generally: much of what employers spend on premiums comes out of wages over time, 2.3% lower wages for a 10% rise in premiums in one widely cited study. And taxpayers, as health care's share of the economy keeps rising.

In October 2026, premiums insurers charged for the same policies were 6.9% higher than a year earlier, as the Producer Price Index measures them. In October 2026, hourly pay was 3.3% higher than a year earlier.

Health insurance premiums for the same policies (PPI), hourly pay and consumer prices, each against a year earlier. When the premium line runs above pay, the cost of covering a worker is growing faster than the paycheck. Full chart and context →

Single payer

Single payer means one public plan pays for everyone's care, financed by taxes, while doctors and hospitals stay mostly private. The best-known version, the Medicare for All Act, was reintroduced on April 29, 2025 by Sen. Bernie Sanders (S. 1506) and Reps. Pramila Jayapal and Debbie Dingell (H.R. 3069); by late October 2026 it had 18 cosponsors in the Senate and 114 in the House. It would cover everyone with no premiums, deductibles or copays (the Senate bill lets the government set small copays for some prescription drugs), phase in over two years in the House version and four in the Senate's, bar private insurers from selling coverage that duplicates it, and set aside at least 1% of the national health budget for up to five years to help workers whose jobs it eliminates.

Who gains. People without coverage, and people whose coverage leaves large bills: no premiums, and no deductible, which averaged $1,955 for single coverage through work in 2026 (KFF). Patients, who could see any participating doctor or hospital, with no networks. Employers, which would stop paying premiums, and state and local governments, which would stop paying their share of Medicaid and their employees' coverage: for its most generous version, the Urban Institute estimated in 2019 that spending by households, employers and state and local governments would fall by about $27 trillion over 2020–29, against $34.0 trillion more federal spending. Hospitals that treat mostly Medicaid and uninsured patients, which would be paid for every patient; in the Crowe analysis below, about one hospital in ten would gain. And doctors and hospitals would bill one payer under one set of rules, which, with lower insurer overhead, is where the administrative savings supporters count would come from.

Who pays. Health insurers, whose main business would end, and the 430,000 people who worked at health and medical insurers in May 2023, along with many in hospitals' and doctors' billing offices. Robert Pollin, who led a 2018 University of Massachusetts analysis funded by National Nurses United, which supports single payer, put the jobs made redundant at about 1.8 million; the analysis proposed an average of a year of full wage replacement, plus retraining and relocation. Drugmakers, because the bills have the government negotiate drug prices: the 2026 Yale study below counts $378 billion a year in lower drug spending. Doctors whose private fees run above Medicare's, and hospitals with many privately insured patients, if everyone is paid Medicare's rates: a 2019 analysis by the consulting firm Crowe found 90% of hospitals would lose revenue, about $200 billion a year in all, and a 2019 JAMA viewpoint put the loss at $151 billion, 15.9% of revenue. Taxpayers, because almost all spending moves onto the federal budget: RAND estimated that in 2019 federal health spending would have risen from $1.09 trillion to $3.50 trillion while total spending rose 1.8%. Whether a given household comes out ahead depends on whether its new taxes are smaller than the premiums, deductibles and copays it stops paying, and the bills don't say what the taxes would be. Sanders has published a list of options that includes a 7.5% payroll premium paid by employers and a 4% income-based premium paid by households. And people who like the coverage they have would have to leave it.

Support moves with how the trade is described. In KFF's September 2026 poll, 66% favored Medicare for All. Told it would guarantee health insurance as a right for all Americans, 76% favored it, and told it would eliminate all premiums and reduce out-of-pocket costs, 75% did; told it would eliminate private insurance companies, 52% did. Told it would require most Americans to pay more in taxes, threaten the current Medicare program, or lead to delays in some tests and treatments, 64%, 61% and 76% opposed it.

What it would cost. Estimates disagree mostly about one thing: what the plan would pay doctors, hospitals and drugmakers.

EstimatePeriodNational health spendingFederal spending
CBO, five designs (2020)2030−$743 billion to +$290 billion (−11% to +4%)+$1.5 trillion to +$3.0 trillion
Mercatus Center (2018)2022–31about $2 trillion (3.4%) lower over ten years+$32.6 trillion over ten years
RAND (2019)2019+1.8%$1.09 trillion to $3.50 trillion
Urban Institute, enhanced version (2019)2020+$720 billion (+21%)+$2.8 trillion ($34.0 trillion over 2020–29)
Urban Institute, "lite" version (2019)2020−$210 billion (−6%)+$17.6 trillion over 2020–29
Galvani and others, Yale (2020)2017−$458 billion (−13%)—
Pandey and others, Yale (2026, not peer reviewed)2024−$1.04 trillion (−20%)—

The low estimates assume providers are paid at or near Medicare's rates and large savings on drugs and administration; the high ones assume payment rates closer to today's, more generous benefits, or both. Urban's two versions show how much the benefits matter: the "lite" one covers legal residents with the ACA's benefits, and the enhanced one covers everyone, including immigrants without legal status, adds dental, vision, hearing and long-term care, and drops cost sharing. CBO's five designs span both: one with lower payment rates and higher cost sharing saved the most, and the one with higher rates, lower cost sharing and long-term care cost the most. Use is the other unknown. Care that is free at the point of service gets used more, if the system can supply it: RAND's 1.8% assumes half of the new demand goes unmet, and without that limit its estimate is 9.8%. Two numbers travel without their footnotes. Supporters often cite CBO's $650 billion in savings; that is one of its five designs, and CBO did not estimate the bill itself. Critics often cite the $32.6 trillion estimated by Charles Blahous of the Mercatus Center, a market-oriented research center at George Mason University; that is federal spending, most of which would replace what households, employers and states pay now. The 2026 Yale study, requested by Rep. Ro Khanna, also estimates 114,000 lives saved a year, about 51,000 of them from reversing 2025 policy changes, including coverage cuts, reduced help with drug costs for low-income seniors and suspended nursing-home staffing rules, rather than from single payer itself; it doesn't model how hospitals and doctors would respond.

The options between

Restore the extra marketplace credits. Making them permanent would cost $350 billion over ten years and leave 3.8 million more people insured in 2035, CBO estimated. People who buy their own coverage would gain, especially those with incomes above four times the poverty line, who now get no credit, and so would insurers and hospitals in places with large marketplaces; federal taxpayers would pay. The House passed a three-year extension 230–196 on January 8, 2026, with 17 Republicans voting yes; the Senate hasn't voted on it, after both a Democratic three-year extension and a Republican plan to put up to $1,500 a year into health savings accounts fell short of the 60 votes needed in December 2025. Before the election, Democratic leaders said restoring the credits would be among their first moves if they won control of Congress, and on November 3 Democrats won majorities in both the House and the Senate, which take over when the new Congress is seated in January 2027. A bill would still need the president's signature, or two-thirds of each chamber to override a veto. The arguments for and against are in what health insurance costs.

A public option. A government plan sold alongside private ones, usually paying providers less than private insurers do. Urban Institute researchers estimated in 2019 that a package of stronger ACA subsidies, reinsurance, a restored individual mandate, subsidies for the poorest adults in states that didn't expand Medicaid, and a public option (or a cap on what individual-market insurers pay providers) would insure about 11 million more people for $590 billion in federal spending over ten years. The public option itself added little coverage; it lowered the cost by lowering premiums. Enrolling the uninsured automatically and letting workers with job-based offers buy subsidized marketplace plans instead would insure 25.6 million more for $1.5 trillion. People who choose a public option pay less if its lower provider payments show up in its premiums; federal taxpayers pay for the subsidies; private insurers face a cheaper competitor; hospitals and doctors are paid less for the patients who switch, and the largest hospital groups have campaigned against both a public option and Medicare for All.

Setting prices without changing who pays. A state or the federal government can set what private insurers pay, or cap it, and leave insurance as it is. Maryland has set hospital rates for all payers for decades, through its Health Services Cost Review Commission. CBO found in 2022 that capping what commercial insurers pay could lower prices more than promoting competition or price transparency, that insurers would pass most of the savings on through lower premiums, and that lower prices could reduce some providers' incomes and some aspects of quality and access. Employers and people with private insurance would gain; hospitals and doctors would lose the revenue above the cap.

The administration's approach. The Great Healthcare Plan President Trump sent Congress in January 2026 would send the subsidy money now paid to insurers on enrollees' behalf "directly to eligible Americans"; the president described it as money put into a health savings account in each person's name. It would also write the administration's most-favored-nation drug pricing deals into law, move more drugs over the counter, fund the cost-sharing reductions that lower out-of-pocket costs for low-income buyers of silver plans, require providers and insurers that take Medicare or Medicaid to post prices, and require insurers to publish denial rates and how much of each premium goes to claims. Supporters say money in patients' hands lets them buy the coverage they choose and spend it more wisely, and that posted prices make hospitals and insurers compete; the White House says funding cost-sharing reductions would cut premiums for the most common marketplace plans by more than 10% and save taxpayers at least $36 billion, citing CBO. Critics say the White House hadn't said how much people would receive or who would qualify, that similar proposals have helped higher earners more, that money paid to people instead of toward premiums could, in the words of KFF's Cynthia Cox, send the marketplace into a "death spiral" as healthier buyers leave, and that funding cost-sharing reductions could raise what many subsidized buyers pay for bronze and gold plans even as silver premiums fall. If it worked as intended, drug buyers would gain and drugmakers would pay, and so would people who want to manage their own money; if healthier buyers left the marketplace, sicker enrollees would pay. Congress hasn't voted on the plan; it did pass changes to how pharmacy benefit managers are paid in February 2026.

Where the analogy breaks

Sellers can leave the bazaar, or stay and serve fewer people. A buyer that posts prices too low doesn't simply save money: hospitals close units, doctors retire or limit new patients, and waits grow. Canadians wait far longer for specialists than insured Americans do, and the median wait from a family doctor's referral to treatment in Canada was 28.6 weeks in 2025 in the survey of physicians by the Fraser Institute, a market-oriented Canadian think tank. Waits are only part of access: the Commonwealth Fund's 2024 comparison, which also counts what care costs patients, ranked the United States last of ten countries on access to care, and last overall. The United States had fewer practicing doctors and nurses per person than the median OECD country in 2015 (Anderson and others), though a comparison with ten high-income countries found little difference (Papanicolas and others); either way, how much care the system can supply limits any plan that makes care cheaper to use.

Shoppers can't haggle from a stretcher. The 5% of people with the highest medical bills accounted for 52.9% of spending in 2020, a pandemic year, and the half with the lowest for 2.6%. Much of the money goes to people with serious or chronic illness, for whom comparing prices is hard, which limits what shopping can do, and is why supporters of the shopper-driven approaches lean on posted prices and drug deals as much as on accounts. Subsidies, whether tax credits or accounts, also add money to the bazaar without changing what the stalls charge, and some of it can end up in prices.

And the single buyer is also the government. A public price list is set by Congress and agencies, under budget pressure and lobbying from every side, and it changes with elections. A private price list is set by bargaining power, which in many markets belongs to a few large hospital systems: among the privately insured, hospitals with no nearby competitor charged about 12% more than those with four or more.

What people argue about

Whether lower prices mean less care. One side: hospitals already lose money treating patients in traditional Medicare, a margin of −12.1% in fiscal 2024 by the count of Medicare's own advisers, and make it up on private insurance, so paying everyone Medicare's rates would close hospitals or departments. The American Hospital Association says Medicare paid 83 cents for every dollar hospitals spent caring for Medicare patients in 2023. CBO expected its designs with lower payment rates to leave more demand unmet, meaning delays and forgone care; in Canada waits are long; and Medicaid, which generally pays less than Medicare, is accepted by fewer doctors: 70.8% of physicians took new Medicaid patients, against 85.3% for Medicare and 90.0% for private insurance, in data from 2014–15. The other: private insurers pay hospitals 254% of Medicare on average; for the median hospital MedPAC judged relatively efficient, the Medicare margin was −1%, close to breaking even; the United States pays far more than other countries for the same care without using more of it; and supporters count savings that offset part of the cut. The 2026 Yale study puts the cut from paying Medicare's rates at $296 billion a year, partly offset by $198 billion for additional care and $52 billion for care hospitals now give without being paid. Part of the disagreement is how far hospitals' costs would fall if their revenue did, and how fast.

Who would pay, and whether households would come out ahead. One side: households already pay for health care through premiums, deductibles, copays and lower wages, since employers' premiums come out of pay, so replacing all of that with taxes can leave most households ahead; Urban's 2019 estimate counts about $27 trillion less spent by households, employers and states over ten years; and nearly half of working-age adults are uninsured or underinsured now. The other: the new federal spending, $32.6 trillion in Mercatus's estimate and $34.0 trillion in Urban's for its most generous version, would take taxes reaching well beyond high earners, and taxes that large carry economic costs of their own; the bills don't specify them; and nothing guarantees that employers would pass their savings on as higher pay, or how quickly. Both rest on assumptions about how the money would flow back, which no estimate can settle in advance.

Whether markets or government hold prices down better. One side: posted prices, competition among hospitals and insurers, enforcement against hospital mergers, and patients who control their own money push prices down without a government monopoly on buying, and keep choices that a single plan would take away. The other: health care is a poor market, because patients can't shop in an emergency, can't easily judge quality and are insured against prices; other countries pay less because governments set or negotiate prices, and in the United States the lowest prices are the ones government programs set. Each side has evidence: prices rose more than 6% after mergers of hospitals within five miles of each other, which supports enforcing competition, and CBO's 2022 report found price caps would lower prices more than competition or transparency policies would, while warning of effects on quality and access. Both sides cite the same finding, that hospitals with fewer competitors charge private insurers more, as evidence for their remedy.

How much disruption is worth it. Gallup found Americans split 46% to 48% between a government-run system and one based mostly on private insurance in late 2025, while 64% said it is the federal government's responsibility to make sure everyone has coverage, the most since 2007. Single payer changes the most and promises the most; the options between change less, cost taxpayers less, and leave more people uninsured or with large bills. Weighing that is a matter of values as much as evidence.

See also

Sources

The weekly digest

One email on Monday mornings: the week's new articles and charts, the numbers that moved most, and what comes out in the week ahead. No ads, and no tracking of opens or clicks.

Past issuesHow addresses are kept